Impact of Cell of Origin, MYC/BCL2 Dual Expression and MYC Rearrangements in Diffuse Large B-Cell Lymphoma Patients Treated with Combined Modality Therapy

被引：0
|
作者：
Augustyn, A. [1 ]
Gunther, J. R. [1 ]
Medeiros, L. J. [2 ]
Milgrom, S. A. [1 ]
Nastoupil, L. [3 ]
Neelapu, S. S. [3 ]
Nair, R. [3 ]
Li, S. [2 ]
Ok, C. Y. [2 ]
Steiner, R. E. [3 ]
Iyer, S. P. [3 ]
Ahmed, S. [3 ]
Westin, J. [3 ]
Rodriguez, M. A. [3 ]
Pasalic, D. [1 ]
Fayad, L. [3 ]
Samaniego, F. [3 ]
Dabaja, B. [1 ]
Pinnix, C. C. [4 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Div Radiat Oncol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2019年 / 105卷 / 01期
关键词：
D O I：
10.1016/j.ijrobp.2019.06.368
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1288
引用
收藏
页码：S248 / S248
页数：1
相关论文
共 50 条
  • [1] Diffuse Large B-Cell Lymphoma in Kenya: MYC, BCL2, and the Cell of Origin
    Wawire, Jonathan
    Sayed, Shahin
    Moloo, Zahir
    Sohani, Aliyah R.
    JOURNAL OF GLOBAL ONCOLOGY, 2019, 5 : 1 - 8
  • [2] The impact of cell-of-origin, MYC/Bcl-2 dual expression and MYC rearrangement on disease relapse among early stage diffuse large B-cell lymphoma patients treated with combined modality therapy
    Augustyn, Alexander
    Medeiros, L. Jeffrey
    Ludmir, Ethan B.
    Gunther, Jillian
    Fang, Penny
    Li, Shaoying
    Ok, Chi Young
    Bankston, Mikaela E.
    Verma, Vivek
    Pasalic, Dario
    Ahmed, Sairah
    Nastoupil, Loretta J.
    Westin, Jason R.
    Strati, Paolo
    Neelapu, Sattva S.
    Nair, Ranjit
    Steiner, Raphael E.
    Iyer, Swaminathan P.
    Rodriguez, Alma
    Fayad, Luis E.
    Flowers, Christopher R.
    Dabaja, Bouthaina S.
    Pinnix, Chelsea C.
    LEUKEMIA & LYMPHOMA, 2021, 62 (06) : 1361 - 1369
  • [3] Complex BCL2/IGH/MYC rearrangements in diffuse large B-cell lymphoma
    Sales, Mark
    Cunningham, J. J. P.
    Kernohan, N. M.
    Smith, G. D.
    Maliszewska, C. T.
    Pratt, N. R.
    JOURNAL OF MEDICAL GENETICS, 2007, 44 : S132 - S132
  • [4] Clinical relevance of MYC/BCL2 expression and cell of origin in patients with diffuse large b-cell lymphoma treated with autologous transplant
    Al-Juhaishi, Taha
    Wang, Yingjun
    Milton, Denai R.
    Xu-Monette, Zijun Y.
    Jabbour, Elias
    Daher, May
    Im, Jin S.
    Bashir, Qaiser
    Iyer, Swaminathan P.
    Marin, David
    Olson, Amanda L.
    Popat, Uday
    Qazilbash, Muzaffar
    Rondon, Gabriela
    Gulbis, Alison M.
    Champlin, Richard E.
    Young, Ken H.
    Khouri, Issa F.
    BONE MARROW TRANSPLANTATION, 2023, 58 (09) : 1000 - 1007
  • [5] Clinical relevance of MYC/BCL2 expression and cell of origin in patients with diffuse large b-cell lymphoma treated with autologous transplant
    Taha Al-Juhaishi
    Yingjun Wang
    Denái R. Milton
    Zijun Y. Xu-Monette
    Elias Jabbour
    May Daher
    Jin S. Im
    Qaiser Bashir
    Swaminathan P. Iyer
    David Marin
    Amanda L. Olson
    Uday Popat
    Muzaffar Qazilbash
    Gabriela Rondon
    Alison M. Gulbis
    Richard E. Champlin
    Ken H. Young
    Issa F. Khouri
    Bone Marrow Transplantation, 2023, 58 : 1000 - 1007
  • [6] Interpreting MYC and BCL2 in diffuse large B-cell lymphoma
    Lai, Catherine
    Grant, Cliona
    Dunleavy, Kieron
    LEUKEMIA & LYMPHOMA, 2013, 54 (10) : 2091 - 2092
  • [7] Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma
    Kramer, MHH
    Hermans, J
    Wijburg, E
    Philippo, K
    Geelen, E
    van Krieken, JHJM
    de Jong, D
    Maartense, E
    Schuuring, E
    Kluin, PM
    BLOOD, 1998, 92 (09) : 3152 - 3162
  • [8] MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximab
    Perry, Anamarija M.
    Alvarado-Bernal, Yuridia
    Laurini, Javier A.
    Smith, Lynette M.
    Slack, Graham W.
    Tan, King L.
    Sehn, Laurie H.
    Fu, Kai
    Aoun, Patricia
    Greiner, Timothy C.
    Chan, Wing C.
    Bierman, Philip J.
    Bociek, Robert G.
    Armitage, James O.
    Vose, Julie M.
    Gascoyne, Randy D.
    Weisenburger, Dennis D.
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 165 (03) : 382 - 391
  • [9] MYC rearrangement and MYC/BCL2 double expression but not cell-of-origin predict prognosis in R-CHOP treated diffuse large B-cell lymphoma
    Xu, Jie
    Liu, Jing-Lan
    Medeiros, L. Jeffrey
    Huang, Wenting
    Khoury, Joseph D.
    McDonnell, Timothy J.
    Tang, Guilin
    Schlette, Ellen
    Yin, C. Cameron
    Bueso-Ramos, Carlos E.
    Lin, Pei
    Li, Shaoying
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 104 (04) : 336 - 343
  • [10] Dual expression of MYC and BCL2 proteins predicts worse outcomes in diffuse large B-cell lymphoma
    Schneider, Kelli M. Clark
    Banks, Peter M.
    Collie, Angela M. B.
    Lanigan, Christopher P.
    Manilich, Elena
    Durkin, Lisa M.
    Hill, Brian T.
    Hsi, Eric D.
    LEUKEMIA & LYMPHOMA, 2016, 57 (07) : 1640 - 1648
12345